ClinicalTrials.Veeva

Menu

Predictive Value of a SNP Signature and Liquid Biopsy in Natural Killer T-cell Lymphoma

Sun Yat-sen University logo

Sun Yat-sen University

Status

Enrolling

Conditions

Natural Killer T-cell Lymphoma

Study type

Observational

Funder types

Other

Identifiers

NCT04423536
B2020-035

Details and patient eligibility

About

The purpose of this study is to determine the Predictive value of a SNP signature and liquid biopsy in patients with natural killer T-cell lymphoma.

Enrollment

800 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • biopsy proved Natural Killer T-cell Lymphoma
  • newly diagnosed patients

Exclusion criteria

  • patients with biopsy samples unavailable

Trial design

800 participants in 2 patient groups

tested group
controlled group

Trial contacts and locations

1

Loading...

Central trial contact

Qing qing Cai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems